WDB coco CoTSE:7079 +1.39%72 Days Payable is 11.41 as of Mar. 2026, which is 9% above its 10-year median of 10.50. GuruFocus rates TSE:7079 with a GF Score™ of 72/100 and a GF Value™ of 円3,456.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 605 Healthcare Providers & Services companies, WDB coco Co ranks worse than 91.74% on this metric.
The historical rank and industry rank for WDB coco Co's Days Payable or its related term are showing as below:
TSE:7079'
s Days Payable Range Over the Past 10 Years
Min: 9.32 Med: 10.5 Max: 11.36
Current: 10.71
During the past 9 years, WDB coco Co's highest Days Payable was 11.36. The lowest was 9.32. And the median was 10.50.
TSE:7079's Days Payable is ranked worse than 91.74% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs TSE:7079: 10.71
WDB coco Co's Days Payable
increased
from Mar. 2025 (9.83) to Mar. 2026 (11.41).
It may suggest that WDB coco Codelayed paying its suppliers.
WDB coco Co Days Payable Related Terms
WDB coco Co Days Payable Historical Data
* Premium members only.
The historical data trend for WDB coco Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7079 vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, WDB coco Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Days Payable distribution charts can be found below:
* The bar in red indicates where WDB coco Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
WDB coco Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WDB coco Co (TSE:7079) has a Days Payable of 11.41 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on WDB coco Co and its competitors. This is near median its historical median of 10.50. Over the past decade, WDB coco Co's Days Payable has ranged from 9.32 to 11.36. According to the industry distribution chart, WDB coco Co ranks #555 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 91.7%.
Is WDB coco Co's Days Payable too high?
WDB coco Co's current Days Payable of 11.41 is near median its 10-year median of 10.50. Over the past 10 years, this metric has ranged from a low of 9.32 to a high of 11.36. The Healthcare Providers & Services industry median Days Payable is 58.00. WDB coco Co's value of 11.41 is 80.3% below this industry median. Based on the distribution chart, WDB coco Co ranks #555 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, WDB coco Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #555 out of 605 companies for Days Payable. This places WDB coco Co in the lower half of its industry. The industry median Days Payable is 58.00. WDB coco Co's value of 11.41 is 80.3% below this benchmark. Historically, WDB coco Co's own Days Payable has ranged from 9.32 to 11.36 over the past decade. While the company's 10-year median is 10.50 vs. the industry median of 58.00, WDB coco Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current Days Payable of 11.41 is 80.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current Days Payable is 11.41, which is near median its own 10-year median of 10.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,456.85, compared to a current price of 円2,618.00 — trading 24.3% below its estimated fair value. The current Days Payable is 11.41, which is near median its 10-year median of 10.50 and 80.3% below the Healthcare Providers & Services industry median of 58.00. WDB coco Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current Days Payable is 11.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,618.00 is trading 24.3% below its estimated GF Value™ of 円3,456.85.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
Days Payable: 11.41 (near median its 10-year median of 10.50)
GF Value™: 円3,456.85 vs. price of 円2,618.00 (24.3% below fair value)
Industry Position: 80.3% below the Healthcare Providers & Services median (#555 of 605)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
72GF Score
Get the complete analysis for TSE:7079
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
